Average Co-Inventor Count = 3.74
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Eli Lilly and Company (20 from 4,446 patents)
2. G.d. Searle & Company (5 from 1,323 patents)
3. Pharmacia Corporation (5 from 200 patents)
4. Other (1 from 832,843 patents)
31 patents:
1. 9550774 - Dihydropyrido pyrimidine compounds as autotaxin inhibitors
2. 9394317 - Imidazo pyridine compounds
3. 8969555 - Bicyclic pyrimidine compounds
4. 8648200 - Imidazole derivatives useful for the treatment of arthritis
5. 8093302 - Substituted tetralins as selective estrogen receptor-β agonists
6. 7842822 - Substituted benzopyrans as selective estrogen receptor-beta agonists
7. 7585985 - Substituted benzopyrans as selective estrogen receptor-beta agonists
8. 7442812 - Substituted benzopyrans as selective estrogen receptor-beta agonists
9. 7354951 - Substituted benzopyrans as selective estrogen receptor-beta agonists
10. 7279499 - Substituted benzopyrans as selective estrogen receptor-beta agonists
11. 7217734 - Substituted benzopyrans as selective estrogen receptor-beta agonists
12. 6998415 - Substituted sulfonylphenylheterocycles as cyclooxygenase-2 and 5-lipoxygenase inhibitors
13. 6875785 - Heterocyclo substituted hydroxamic acid derivatives as cyclooxygenase-2 and 5-lipoxygenase inhibitors
14. 6753344 - Thiophene substituted hydroxamic acid derivatives as cyclooxygenase-2 and 5-lipoxygenase inhibitors
15. 6743794 - Methods and compounds for inhibiting MRP1